Literature DB >> 15576936

E2F transcription factors and pRb pocket proteins in cell cycle progression.

Ludger Hauck1, Rüdiger von Harsdorf.   

Abstract

The E2F-family of transcripion factors exerts fascinating and contrasting functions in transcriptional repression and activation of genes regulating proliferation, apoptosis, and differentiation. E2F is principally regulated by its temporal association with retinoblastoma pocket protein (pRb) family members. In turn, pRb is regulated through phosphorylation by cyclin-dependent kinase (cdk). The activity of cdk is negatively regulated by cdk-inhibitors, exemplified by p16INK4a, p21CIP1, and p27KIP1. Therefore, positive and negative signaling events converge on E2F activity resulting in distinct growth-controling and apoptotic activities. Here we describe the immunocytochemical detection of E2F, genomic DNA, BrdU-incorporation, and mitosis in cardiomyoctes. A detailed protocol is given to illustrate this technique in primary heart muscle cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15576936     DOI: 10.1385/1-59259-857-9:239

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  3 in total

1.  Thiazolides promote G1 cell cycle arrest in colorectal cancer cells by targeting the mitochondrial respiratory chain.

Authors:  P Ripani; J Delp; K Bode; M E Delgado; L Dietrich; V M Betzler; N Yan; G von Scheven; T U Mayer; M Leist; T Brunner
Journal:  Oncogene       Date:  2019-12-16       Impact factor: 9.867

2.  Ectopic expression of E2F1 stimulates beta-cell proliferation and function.

Authors:  Gael Grouwels; Ying Cai; Inge Hoebeke; Gunter Leuckx; Yves Heremans; Ulrike Ziebold; Geert Stangé; Marie Chintinne; Zhidong Ling; Daniel Pipeleers; Harry Heimberg; Mark Van de Casteele
Journal:  Diabetes       Date:  2010-03-18       Impact factor: 9.461

3.  PAQR4 promotes cell proliferation and metastasis through the CDK4-pRB-E2F1 pathway in non-small-cell lung cancer.

Authors:  Bin Wu; Rongyu Liu
Journal:  Onco Targets Ther       Date:  2019-05-13       Impact factor: 4.147

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.